J&J ex­pands deal with lit­tle-known Welsh biotech us­ing 3D print­ing to bet­ter en­cap­su­late drugs

J&J is dou­bling back to a small part­ner af­ter its orig­i­nal col­lab­o­ra­tion agree­ment proved a suc­cess.

The com­pa­ny is team­ing up again with Welsh biotech Mi­dat­e­ch Phar­ma on a sec­ond com­pound, Mi­dat­e­ch an­nounced Wednes­day, with a fo­cus on de­vel­op­ing a large mol­e­cule drug. No fi­nan­cials were dis­closed in the an­nounce­ment, but Mi­dat­e­ch not­ed the J&J col­lab­o­ra­tion first got un­der­way about two years ago.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.